EGFR and diabetes mellitus: In a model of streptozotocin-induced diabetes, the genetic blockade of EGFR or pharmacological inhibition using erlotinib showed a downregulation of phospho-AKT, CTGF, and AREG expression compared to that in diabetic mice [155].